China’s Therapeutic mRNA Vaccine Pipeline For Oncology The Largest Globally
Nearly half of the mRNA-based therapeutic vaccines for cancer in the R&D pipeline globally are from Chinese companies, although financing activities in the area have been relatively quiet so far this year in China compared with 2020-23.
Scrip - September 16, 2025

Morphic Medical Prepares RESET Rollout In UK And Germany, Eyes Global Expansion In 5 Years
The company is undergoing major leadership changes, having appointed 30-year medtech veteran Jane Wright as chief financial officer on Sept. 12. Wright’s appointment follows Gutteridge’s own transition to CEO earlier this year.
Medtech Insight - September 16, 2025

Advertising Claim Review For Coffee With Benefits: Eye-Opener For Firms In Percolating Market?
Ryze Superfoods withdraws claims National Advertising Division asks to review from its ongoing monitoring of consumer products advertising, including that coffee enhances mental acuity and provides other health benefits.
HBW Insight - September 16, 2025

EU Critical Medicines Act: Parliament Clarifies ‘Significant Proportion’ Rule
The European Parliament has suggested clear rules on the proportion of medicinal product manufacturing that must take place in the EU, EEA, or Switzerland for drugmakers to be favored under the Critical Medicines Act, which aims to drive investment in Europe.
Generics Bulletin - September 15, 2025

Kashiv Bags A LATAM Deal With Cristália For Xolair Biosimilar
Kashiv has landed another deal for its omalizumab biosimilar, this time with Brazil-based Cristália in Latin America.
Generics Bulletin - September 15, 2025

Adcock Pushes On With Natco Deal As Wadeville Remains Problem Child
Adcock Ingram celebrated a minor turnaround in the back half of its 2025 financial year, though its Prescription division trading profit still fell well short of last year’s level.
Generics Bulletin - September 15, 2025

Deals Shaping The Industry, August 2025
An interactive look at pharma, medtech and diagnostics deals made during August 2025. Data courtesy of Biomedtracker.
In Vivo - September 15, 2025

Rising Leaders 2025: Noam Solomon’s Quest To Create A ‘Google Maps’ Of the Immune System
The mathematician-turned-CEO is building an atlas of clinical immune biology to revolutionize precision medicine.
In Vivo - September 15, 2025

2030’s Top Therapies: Incretin Agonists Loom Large
In Vivo looks at the therapies projected to lead global sales by 2030. These frontrunners not only reflect advances in innovation but also shifting priorities in chronic disease management.
In Vivo - September 15, 2025